版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领
文档简介
DegenerationACUTECELLULARSWELLING
Excessiveentryoffreefattyacidsintotheliver(starvation,corticosteroidtherapy).Enhancedfattyacidsynthesis.Decreasedfattyacidoxidation.Increasedesterificationoffattyacidtotriglycerides(alcohol).Decreasedapoproteinsynthesis(CCl4).Impairedlipoproteinsecretionfromtheliver(alcohol).FATTYCHANGEMorphologyoffattychangeSudanIII,OilredO,OsmicacidLiverHeartKidneyIntracellularhyalinechangesHyalinedegenerationofarteriolesHyalinedegenerationofconnectivetissueHyalinechanges(degeneration)Absorptionofproteincausinghyalinedropletsinproximalepithelialcellsinthekidney.Russelbodiesinplasmacells.Viralinclusionsinthecytoplasmorthenucleus.Massesofalteredintermediatefilaments(Mallorybodies).IntracellularhyalinechangesAheterogeneousgroupofpathogenicfibrillarproteinsaccumulatingintissuesandorgans.ExcesssynthesisResistancetocatabolismAMYLOIDOSISChemicalnatureofamyloidfibrilsTwomajorforms:AL(amyloidlightchainprotein)AA(amyloid-associatedprotein):
DerivedfromserumAA(12kd)synthesizedinliverandelevatedininflammatorystates.Minorformsofamyloidfibrils:Transthyretin(TTR):Amutantformofaserumproteininfamilialamyloidpolyneuropathy.AvariantofTTRinaging.Beta-2-microglobulin(thecomponentofclassIMHCmolecules)inlong-termhemidialysis.Minorformsofamyloidfibrils:
Beta-2-amyloidproteinformsthecoreofcerebralplaquesanddepositswithincerebralvesselwallsinAlzheimerdisease,derivingfromatransmembraneglycoproteinprecursor.Minorformsofamyloidfibrils:Transthyretin(TTR):Amutantformofaserumproteininfamilialamyloidpolyneuropathy.AvariantofTTRinaging.Beta-2-microglobulin(thecomponentofclassIMHCmolecules)inlong-termhemidialysis.Minorformsofamyloidfibrils:
Beta-2-amyloidproteinformsthecoreofcerebralplaquesanddepositswithincerebralvesselwallsinAlzheimerdisease,derivingfromatransmembraneglycoproteinprecursor.primary(B-celldyscrasia,AL)Secondaryorreactive(AA):Collagendiseases,bronchiectasis,chronicosteomyelitis.Hemodialysis-related:Beta-2-microglobulindeposition.Hereditary(AA)ClinicalformsofamyloidosisSystemicamyloidosis:Nodular(tumor-formingdeposits,B-celldyscrasia,AL)Endocrineamyloidosis(procalcitonin)Amyloidosisofaging:Heart,lung,pancreas,spleen,brain.Localizedamyloidosis
Exogenous:
CarbonTattooingEndogenous:LipofuscinMelaninHemosiderinBilirubinPigmentationDystrophiccalcificationMetastaticcalcificationPathologiccalcificationNecrotictissuesAtheromaDamagedheartvalvesDystrophiccalcificationFig2-13IncreasedsecretionofparathyroidhormoneDestructionofbonetissueVitaminD-relateddisorders:SarcoidosisRenalfailureMetastaticcalcificationHypercalcimiaMetastaticcalcificationAffectingInterstitialtissueofgastricmucosaKidneysLungsPulmonaryveinsSystemicarteriesHyperemia:
ArterialhyperemiaVenoushyperemia
ChapterFour
HemodynamicDisordersArterialhyperemiaInflammatoryCollateralPost-ischemicVenoushyperemiaSystemiccongestionHeartfailuresLocalcongestion1.Externalpressure2.Thrombosis3.Venousvalves4.CollateralEdemaHemorrhageHeartfailurecellsBrownindurationPulmonarycongestionLivercongestionAtrophyFattychangeNutmegliverCentrilobularnecrosiscardiaccirrhosisINFARCTION(INFARCT)
ThrombosisEmbolismVesospasmExpansionofatheromaExtrinsiccompressionTwistingofthevesselsEtiologyINFARCTIONShape:Wedge-shapedSegmentalIrregularNatureofnecrosisTypes:RedandwhiteinfarctsMorphologyofinfarctVenousocclusionsLoosetissuesTissueswithdualcirculationsTissuespreviouslycongestedBloodflowreestablishedRedinfarct
CELLDEATHSwelling,denaturationandcoagulationofproteinsBreakdownofcellularorganellesCellrupture
Commontypeofnecrosisafterexogenousstimuli.NECROSISThesumofthemorphologicchangesthatfollowcelldeathinlivingtissueandorgan:Denaturationofproteins.Enzymaticdigestionoforganellesandcytosol.Enzymaticdigestionbylysosomalenzymesofthedeadcellsthemselves.AUTOLYSISHETEROLYSISDigestionbylysosomalenzymesofimmigrantleukocytes.ThreepatternofnuclearchangesKaryolysis(DNaseactivity)Pyknosis(DNAcondensation)Karyorrhexis(fragmentationofpyknoticnucleus)MorphologicappearanceofnecrosisIncreasedeosinophilia:LossofRNAinthecytoplasmIncreasedbindingofeosintodenaturedcytoplasmic
proteinMoreglassyhomogeneousappearanceLossofglycogenparticlesVacuolatedandmoth-eatencytoplasmCalcificationofnecroticcellsTYPESOFCELLDEATH
necrosis
Coagulationnecrosis
Caseousnecrosis
Gangrene
Liquefactionnecrosis(fatnecrosis)FibrinoidnecrosisApoptosisCoagulationnecrosisDenaturesofbothstructuralandenzymaticproteinsbyinjuryorthesubsequentincreasingintracellularacidosis.CaseousnecrosisAsubtypeofcoagulationnecrosisWhiteandcheesyTuberculosisCompletelyobliteratedtissuearchitectureGangreneAsubtypeofcoagulationnecrosisDrygangreneWetgangreneGasgangreneLiquefactivenecrosisBacterialorfungalinfectionsCentralnervoussystemAmebiasisFatnecrosisTraumaticActivatedpancreaticlipasesFibrinoiddegenerationDeeplyeosinophilicCollagendiseasesNecroticvasculitisMalignanthypertensionAPOPTOSIS(Programmedcelldeath)
Programmeddestructionofcellsduringembryogenesis.Hormonedependentinvolutionoftissuesintheadult.Celldeletioninproliferatingcellpopula-tions(intestinalcryptepithelium),tumors,andlymphoidorgans.Pathologicatrophyinparenchymalorgansafterductobstruction.CelldeathbycytotoxicTcells.Cellinjuryincertainviraldiseases.Celldeathproducedbyavarietyofinjuriousstimuligiveninlowdoses(e.g.mildthermalinjury).MORPHOLOGICALFEATURESOFAPOPTOSISCellshrinkageChromatincondensationandfragmentation.Formationofcytoplasmicblebsandapoptoticbodies.Phagocytosisofapoptoticbodiesbyadjacenthealthycellsormacrophages.Lackofinflammation.
Necrosis
ApoptosisStimuliHypoxiaPhysicalToxinsPathologicalHistology
CellswellingSinglecellCoagulationNChromatinDisruptionofcondensationorganellesApoptoticbodiesDNA
RandomInternucleosomalbreakdown
Diffuse
Necrosis
ApoptosisMechanismATPdepletionGeneactivationMembraneEndonucleaseinjuryFreeradicalsTissueInflammationNoinflammation
reaction
PhagocytosisofapoptoticbodiesFig1-18Biochemicalfeaturesofapoptosis1.PROTEINCLEAVAGE:
Caspases(cysteineprotease)NuclearscaffoldCytoskeletalprotein2.PROTEINCROSS-LINKING:
TransglutaminaseCytoplasmicprotein
shrunkenshalls
apoptoticbodiesBiochemicalfeaturesofapoptosis3.DNAbreakdown:50-300kbpiecesCa2+,Mg2+dependentendonucleasesDNAoligonucleosomesDNAladders(alsoseeninnecrosis)4.PHAGOCYTICRECOGNITION
Receptorsonmacrophagesforthesurfacecomponents(phosphatidylserine,thrombospondin)onapoptoticbodies.Fig1-19Apoptosis-associatedgenesbcl-2,c-myc,p53Fig1-20AbsorptionDischarge:ErosionUlcerSinusFistulaCavitationOrganizationEncapsulationCalcificationFatesofnecrosisRegeneration:CompletelyregenerationFibrousrepairChapterThreeRepairSectionALabilecellsStablecellsPermanentcellsRegenerationcapacity1.Cell-cellinteractionConditionedmediumContactinhibition2.ExtracellularmatrixLaminin:
Epithelia
FibroblastsFibronectin:
Epithelia
Fibroblasts3.GrowthfactorsFactorsinfluencingregenerationGROWTHFACTORSEGF,TGF-A,PDGF,aFGF,bFGF,IGF-1,IGF-2,VEGF,HGF,MG-CSF,M-CSF,G-CSF,ERYTHROPOITIN,ILs,TNF,IFN,NGF.SectionB
FibrousRepair
Granulationtissues:NewlyformedcapillariesFibroblastsInflammatorycellsGranulationtissuesFibrousrepairOrganizationWoundhealingFig4-14Fig4-15HealingbyfirstintentionHealingbysecondintentionHealingunderscabWoundhealingFig4-18Fig4-19Systemicfactorsinfluencingwoundhealing:
NutritionMetabolicstatusCirculatorystatusHormonesInfectionMechanicalfactorsForeignbodiesSize,locationandtypesofwoundLocalfactorsinfluencingwoundhealing:LiquefactivenecrosisBacterialorfungalinfectionsCentralnervoussystemAmebiasisFatnecrosisTraumaticActivatedpancreaticlipasesEmbolismEmbolusEmboli
EmbolusfromleftheartcavityorarterialsystemEmbolusfromrightheartcavityorvenoussystemEmbolusfromportalveinsParadoxicalembolismRetrogradeethrombusMotionalpathwayofembolus:Fig5-16THROMBOEMBOLISMInstantaneousdeath(>60%).Cardiovascularcollapse.Hemodynamiccompromise.Pulmonary1.Largeemboli(5%):2.Smallemboli(60-80%):Clinicalsilentinpatientswithoutcardiovascularfailure.Infarctionsinthosewithcompromisedpulmonarycirculation(10-15%).3.Betweentheextremesoflargeandsmallemboli(10-15%):Pulmonaryhemorrhage.4.Multipleovertorcovertsmallemboli:Pulmonaryhypertensionandvascularsclerosis.SystemicembolismI.80-85%fromheart,secondarytomyocardialinfarction.II.5-10%fromauricularthrombiassociatedwithrheumatic heartdiseaseandatrialfibrillation.III.5%fromthedilatedcardiacchamberofmyocarditis/ cardiomyopathy.VI.Lesscommonsources:Debrisfromulcerativeatheromata, orthrombiinaneurysms,infectiousendocarditis, prostheticvalves,paradoxicalemboli.V.Unknown.Etiology:FracturesoflongbonesSofttissuetraumaBurnsFatembolism90%ofindividualswithsevereskeletalinjuries10%withclinicalfindingsPulmonaryinsufficiencyNeurologicsymptoms9-20gFatembolismFig5-17Etiology:IntravenoustherapeuticproceduresObstetricproceduresChestwallinjuryDecompressionsickness(nitrogen)AirembolismClinicaleffect:>100ccBends,focalischemiaAtelectasisandemphysema(choke)Caissondisease(amorechronicform):Multiplefociofischemicnecrosisinskeletalsystem(femurs,tibia,humor)AirembolismAMNIOTICFLUIDINFUSIONIncidence:1/50000deliveriesMortalityrate:80%Clinicalonset:Suddenseveredyspnea,cyanosis,hypotensiveshock,seisuresandcoma.AMNIOTICFLUIDINFUSIONEmbolizationofthepulmonarymicrocirculationoftheparticulatedebrisinamnioticfluid.Releaseofvasoconstrictoragents,e.g.,PGreducingpulmonarybloodflow.IntercurrenceofDIC.Cellularadaptation:AtrophyHypertrophyHyperplasiaMetaplasiaChapterTwoTissueinjury
CELLULARADAPTATIONExcessivephysiologicstresses.Somepathologicstimuli.Anew,butalteredstatepreservingtheviabilityofthecell.ATROPHYDecreaseinmassofthecellHYPERTROPHYIncreaseinmassofthecellATROPHYDecreasedworkload.Lossofinnervation.Diminishedbloodsupply.Inadequatenutrition.Lossofendocrinestimulation.AgingMorphologyofatrophyBrownatrophyReductioninthenumberofcellorganelles.Increaseinthenumberofautophagicvacuoles.Lipofuscingranules(Brownatrophy)Fig2-5HYPERTROPHYIncreasedfunctionaldemand.Specifichormonalstimulation.Fig2-6HYPERPLASIAThemythofPrometheus.HYPERPLASIAPhysiologichyperplasia:HormonalhyperplasiaCompensatoryhyperplasiaPathologichyperplasia:Excessivehormonalstimulation.EffectsoflocallyproducedGFsontargetcells.
Fig2-1PARTIALHEPATECTOMYPrimingProliferationGroethlnhibitionGROWTHFACTORSANDCYTOKINESHGFTGF-
EGFTNF-
IL-6OthersADJUVANTSNorepinephrineInsulinGlucagonThyroidhormoneGROWTHINHIBITORSTGF-
OthersGrowthfactorsAdjuvanisMatrixdegradationMetaplasiaOneadultcelltypeisreplacedbyanother.Geneticreprogrammingofstemcells.Epithelialandmesenchymalmetaplasia.Squamousmetaplasia
BronchialepitheliaEpitheliainbileductCervicalepitheliaIntestinalmetaplasiaofgastricepitheliaBonemetaplasia.ThrombosisThrombusThrombi
ANTITHROMBOTICPROPERTIESInhibitionofplateletaggregation:PGI2,NO,ADPaseAnticoagulant-bindingandinhibitionofthrombin:AntithrombinIIIaccelerationbyheparin-likemolecules,thrombomodulinactivationofproteinC/S,
2-macroglobulin.Fibrinlysis:Tissueplasminogenactivator(tPA)PROTHROMBOTICPROPERTIESSimulationofplateletaggregation(adhesion):vonWillebrandfactor,platelet-activatingfactor.Procoagulationfactors:Tissuefactor,bindingfactorsIXaandXa,FactorV.Inhibitionoffibrinolysis:t-PAinhibitor.Fig5-5Fig5-6THREEINFLUENCESOFTHROMBOSISEndot
温馨提示
- 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
- 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
- 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
- 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
- 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
- 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
- 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
最新文档
- 聊城市一级建造师考试(通信与广电工程管理与实务)真题及答案
- 2026年上半年教师资格证考试《教育教学知识与能力》(小学)真题附答案
- 靶向药物临床应用中国指南(2026 版)
- 居家拔罐保健适用人群与禁忌指南 (2026 版)
- 环保工程工作报告
- Flupenthixol-decanoate-生命科学试剂-MCE
- 护理查房中的患者满意度
- 2026net的面试题及答案
- 2026linux c 面试题及答案
- 恶性肿瘤患者的健康教育
- 银行保安服务投标方案(完整技术标)
- 拒绝文身主题班会课件
- 项目部人员绩效考核表实用文档
- 汽车行走的艺术学习通课后章节答案期末考试题库2023年
- 食品检验工(高级)5
- JJF 1941-2021 光学仪器检具校准规范 高清晰版
- 张爱玲《金锁记》教学课件
- GA/T 1028.2-2022机动车驾驶人考试系统通用技术条件第2部分:驾驶理论考试系统
- GB/Z 26209-2010光辐射探测器光谱响应的确定方法
- 室分交维评估报告-tjd
- 中考语文非连续性文本阅读10篇专项练习及答案
评论
0/150
提交评论